These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7923131

  • 1. Inhibition of topoisomerase I activity by tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action.
    Aflalo E, Iftach S, Segal S, Gazit A, Priel E.
    Cancer Res; 1994 Oct 01; 54(19):5138-42. PubMed ID: 7923131
    [Abstract] [Full Text] [Related]

  • 2. DNA topoisomerase I as one of the cellular targets of certain tyrphostin derivatives.
    Bendetz-Nezer S, Gazit A, Priel E.
    Mol Pharmacol; 2004 Sep 01; 66(3):627-34. PubMed ID: 15322255
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Moloney murine leukemia virus replication by tyrphostins, tyrosine kinase inhibitors.
    Esther A, Iftach S, Esther P.
    FEBS Lett; 1994 Mar 14; 341(1):99-103. PubMed ID: 8137930
    [Abstract] [Full Text] [Related]

  • 4. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.
    Agbotounou WK, Levitzki A, Jacquemin-Sablon A, Pierre J.
    Mol Pharmacol; 1994 May 14; 45(5):922-31. PubMed ID: 7514714
    [Abstract] [Full Text] [Related]

  • 5. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
    Kaur G, Gazit A, Levitzki A, Stowe E, Cooney DA, Sausville EA.
    Anticancer Drugs; 1994 Apr 14; 5(2):213-22. PubMed ID: 8049505
    [Abstract] [Full Text] [Related]

  • 6. Selective inhibition of dexamethasone-induced apoptosis in rat thymocytes by herbimycin A.
    Lee E, Miura M, Yoshinari M, Iwai H, Kariya K.
    Biochem Biophys Res Commun; 1994 Jul 15; 202(1):128-34. PubMed ID: 8037703
    [Abstract] [Full Text] [Related]

  • 7. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability.
    Ramdas L, McMurray JS, Budde RJ.
    Cancer Res; 1994 Feb 15; 54(4):867-9. PubMed ID: 7508821
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
    Sion-Vardy N, Vardy D, Rodeck U, Kari C, Levin RM, Malkowicz SB.
    J Surg Res; 1995 Dec 15; 59(6):675-80. PubMed ID: 8538164
    [Abstract] [Full Text] [Related]

  • 10. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
    Kovalenko M, Gazit A, Böhmer A, Rorsman C, Rönnstrand L, Heldin CH, Waltenberger J, Böhmer FD, Levitzki A.
    Cancer Res; 1994 Dec 01; 54(23):6106-14. PubMed ID: 7954456
    [Abstract] [Full Text] [Related]

  • 11. A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I.
    Komatani H, Morita M, Sakaizumi N, Fukasawa K, Yoshida E, Okura A, Yoshinari T, Nishimura S.
    Cancer Res; 1999 Jun 01; 59(11):2701-8. PubMed ID: 10363995
    [Abstract] [Full Text] [Related]

  • 12. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors.
    Han Y, Caday CG, Nanda A, Cavenee WK, Huang HJ.
    Cancer Res; 1996 Sep 01; 56(17):3859-61. PubMed ID: 8752145
    [Abstract] [Full Text] [Related]

  • 13. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
    Holden JA, Wall ME, Wani MC, Manikumar G.
    Arch Biochem Biophys; 1999 Oct 01; 370(1):66-76. PubMed ID: 10496978
    [Abstract] [Full Text] [Related]

  • 14. BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo.
    Demarquay D, Huchet M, Coulomb H, Lesueur-Ginot L, Lavergne O, Camara J, Kasprzyk PG, Prévost G, Bigg DC.
    Cancer Res; 2004 Jul 15; 64(14):4942-9. PubMed ID: 15256467
    [Abstract] [Full Text] [Related]

  • 15. Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity.
    Labourier E, Riou JF, Prudhomme M, Carrasco C, Bailly C, Tazi J.
    Cancer Res; 1999 Jan 01; 59(1):52-5. PubMed ID: 9892183
    [Abstract] [Full Text] [Related]

  • 16. Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
    Bridewell DJ, Finlay GJ, Baguley BC.
    Anticancer Drug Des; 2001 Dec 01; 16(6):317-24. PubMed ID: 12375884
    [Abstract] [Full Text] [Related]

  • 17. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
    Smith LM, Willmore E, Austin CA, Curtin NJ.
    Clin Cancer Res; 2005 Dec 01; 11(23):8449-57. PubMed ID: 16322308
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and antiproliferative activity of tyrphostins containing heteroaromatic moieties.
    Brunton VG, Lear MJ, Robins DJ, Williamson S, Workman P.
    Anticancer Drug Des; 1994 Aug 01; 9(4):291-309. PubMed ID: 7916898
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of the tyrosine kinase inhibitor tyrphostin on insulin binding and insulin imprinting of Tetrahymena.
    Kovács P, Csaba G.
    Microbios; 1994 Aug 01; 79(318):37-41. PubMed ID: 8078419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.